Cargando…

A case of neurosarcoidosis with aggresive characteristics

Detalles Bibliográficos
Autores principales:	Ugurlu, Serdal, Murt, Ahmet, Seyahi, Emire, Uygunoglu, Ugur, Saip, Sabahattin, Ozdogan, Huri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191568/ http://dx.doi.org/10.1186/1546-0096-12-S1-P289

Ejemplares similares

Infliximab is a plausible alternative for neurologic complications of Behçet disease
por: Zeydan, Burcu, et al.
Publicado: (2016)

Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine
por: Ozdede, Ayse, et al.
Publicado: (2022)

Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center
por: ÖZTAŞ, Mert, et al.
Publicado: (2021)

The frequency of MEFV gene variations in Adult-onset Still's disease and Gout
por: Ugurlu, S, et al.
Publicado: (2015)

Recurrent meningoencephalitis and hyponatremia in childhood neurosarcoidosis
por: Isgro, Josephine, et al.
Publicado: (2012)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
por: Ugurlu, Serdal, et al.
Publicado: (2017)

How safe it is to treat pregnant FMF patients with Anakinra?
por: Ozdogan, H, et al.
Publicado: (2015)

A case with febrile attacks and vasculopathy associated with ADA2 and MEFV gene mutations
por: Ozdogan, H, et al.
Publicado: (2015)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey
por: Ozdogan, H, et al.
Publicado: (2015)

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers
por: Everest, Elif, et al.
Publicado: (2023)

Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2017)

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
por: Avsar, Timucin, et al.
Publicado: (2015)

Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey
por: Baykan, Betul, et al.
Publicado: (2015)

Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey
por: Yurttas, Berna, et al.
Publicado: (2021)

Characteristics of optic neuropathy in Behçet disease
por: Akdal, Gülden, et al.
Publicado: (2018)

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome
por: Ozcifci, Guzin, et al.
Publicado: (2021)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation
por: Everest, Elif, et al.
Publicado: (2022)

Neurosarcoidosis
por: Lacomis, David
Publicado: (2011)

P01-015 – Effect of Cochicine on cholesterol in FMF and BS
por: Ugurlu, S, et al.
Publicado: (2013)

EHMTI-0248. Evaluation of headache prevalence and characteristics in orphans aged 12-17
por: Senturk, A Ates, et al.
Publicado: (2014)

Neurosarcoidosis: A Case Report
por: Nascimento, Margarida L, et al.
Publicado: (2022)

Behçet’s Syndrome and Thrombosis
por: Seyahi, Emire, et al.
Publicado: (2011)

Massive Neurosarcoidosis
por: Ogawa, Yukari, et al.
Publicado: (2017)

A Case of Neurosarcoidosis with Labyrinthine Involvement
por: Johnson, Peter B., et al.
Publicado: (2014)

O08 Neurosarcoidosis mimicking CNS lymphoma
por: Arun, Tarunya
Publicado: (2020)

The radiological investigation of neurosarcoidosis.
por: Ellis, P. K., et al.
Publicado: (1995)

Intramedullary spinal neurosarcoidosis
por: Saadi, Altaf, et al.
Publicado: (2015)

Nemesis of neglected neurosarcoidosis
por: Clifford, David B
Publicado: (2015)

Neurosarcoidosis manifesting as panhypopituitarism
por: Oye, Monique, et al.
Publicado: (2019)

An Unusual Presentation of Neurosarcoidosis
por: Sarac, Erdal, et al.
Publicado: (2022)

Neurosarcoidosis-Induced Panhypopituitarism
por: Alfares, Khalid, et al.
Publicado: (2023)

Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients
por: Yurttaş, Berna, et al.
Publicado: (2020)

Optic Neuropathy and Macular Ischemia Associated with Neurosarcoidosis: A Case Report
por: Tanyıldız, Burak, et al.
Publicado: (2018)

Neurolymphomatosis mimicking neurosarcoidosis: a case report
por: Santos, Ernestina, et al.
Publicado: (2010)

Neurosarcoidosis – A diagnostic challenge?
por: Gupta, Palak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bncm3nrjfa5vh7enq1qo9hc99t